We are investigating new imaging methods to better diagnose Alzheimer's disease in healthy older adults and those with early cognitive symptoms. The goal is to understand brain changes that may lead to dementia.
Health conditions and diseases that the clinical trial is designed to study and treat.
Dementia and neurodegenerative disorders are conditions that lead to a decline in cognitive function, affecting memory, thinking, and behavior. Alzheimer's disease is the most common type, but other forms include progressive supranuclear palsy and frontotemporal dementia, often resulting in symptoms like memory loss, confusion, and difficulty with daily activities.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.